Explore All 2731 Add-on Acquisition Medical Products Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | June 19, 2019 |
| Target | DOSE Medical |
| Sector | Medical Products |
| Buyer(s) | Glaukos |
| Deal Type | Add-on Acquisition |
| Deal Value | 3M USD |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1998 |
| Sector | Medical Products |
| Employees | 995 |
| Revenue | 383M USD (2024) |
Glaukos is a medical device company focused on developing ophthalmic stents for minimally invasive treatment of patients with glaucoma. Glaukos was founded in 1998 and is based in Aliso Viejo, California.
| Deal Context for Buyer | # |
|---|---|
| Overall | 1 of 2 |
| Sector: Medical Products | 1 of 2 |
| Type: Add-on Acquisition | 1 of 2 |
| State: California | 1 of 1 |
| Country: United States | 1 of 2 |
| Year: 2019 | 1 of 2 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-08-07 |
Avedro
Waltham, Massachusetts, United States Avedro, Inc. is a hybrid ophthalmic pharmaceutical and medical technology company focused on treating corneal disease and disorders and improving vision to reduce dependency on eyeglasses or contact lens. Avedro’s proprietary bio-activated pharmaceuticals strengthen, stabilize, and reshape the cornea to treat corneal ectatic disorders and correct refractive conditions. Avedro, Inc. was founded in 2002 and is headquartered in Waltham, Massachusetts. |
Buy | - |
